Liver transplantation for hepatocellular carcinoma with live donors or extended criteria donors: a propensity score-matched comparison

被引:2
作者
Sotiropoulos, Georgios C. [1 ,2 ]
Spartalis, Eleftherios [2 ]
Machairas, Nikolaos [2 ]
Paul, Andreas [1 ]
Malago, Massimo [1 ,3 ]
Neuhaeuser, Markus [4 ]
机构
[1] Essen Univ Hosp, Dept Gen Visceral & Transplantat Surg, Hufelandstr 55, D-45122 Essen, Germany
[2] Univ Athens, Dept Propaedeut Surg 2, Athens, Greece
[3] UCL, Royal Free Hosp, Dept HPB & Liver Transplant Surg, London, England
[4] Koblenz Univ Appl Sci, Dept Math & Technol, Remagen, Germany
来源
ANNALS OF GASTROENTEROLOGY | 2018年 / 31卷 / 06期
关键词
Liver transplantation; live donors; extended criteria donors; propensity score;
D O I
10.20524/aog.2018.0301
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background To compare patient survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) from live donors (LD) or extended criteria donors (ECD). Methods Data from consecutive LT procedures for HCC involving either LD or ECD were reviewed. Patient survival was our primary outcome. Re-transplantation (Re-LT), ischemic type bile lesions (ITBL), and tumor recurrence represented secondary outcomes. The primary outcome was statistically analyzed using Kaplan-Meier estimates and Cox proportional hazards regression; logistic regression analyses were used for statistical analysis of the secondary outcomes. Propensity score was calculated based on patient age, sex, hepatitis C viral infection (HCV), laboratory model for end-stage liver disease (labMELD) score, bridging treatment, Milan criteria, alpha-fetoprotein levels, and tumor grade. Results The study evaluated 109 recipients undergoing LT from either LD (n=57) or ECD (n=52). LT procedure (hazard ratio [HR] 2.349, 95% confidence interval [CI] 1.151-4.794, P=0.0190), age (HR 1.075, 95% CI 1.020-1.133, P=0.0074) and labMELD score (HR 1.082, 95% CI 1.021-1.147, P=0.0075) reached significance by Cox proportional hazards regression. After adjustment with the propensity score (stratification with 5 strata), the LT procedure was still significant (HR 2.401, 95% CI 1.114-5.175, P=0.0253). Tumor grade (odds ratio [OR] 9.628, 95% CI 1.120-82.752, P=0.0391), labMELD score (OR 1.224, 95% CI 1.019-1.471, P=0.0306), and Milan criteria (OR 6.375, 95% CI 1.239-32.796, P=0.0267) gained statistical significance by logistic regression analysis for Re-LT, ITBL, and tumor recurrence, respectively. Conclusions LT for HCC showed superior patient survival with ECD rather than LD grafts. Re-LT, ITBL, and tumor recurrence showed no significant differences between the two groups. However, the diverging criteria for the definition of ECD grafts represent a considerable limitation for the wide application of this policy.
引用
收藏
页码:722 / 727
页数:6
相关论文
共 27 条
[1]   The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers [J].
Benko, Tamas ;
Gallinat, Anja ;
Minor, Thomas ;
Saner, Fuat H. ;
Sotiropoulos, Georgios C. ;
Paul, Andreas ;
Hoyer, Dieter P. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (06) :716-722
[2]   Should we expand the criteria for liver transplantation for hepatocellular carcinoma - Yes, of course! [J].
Broelsch, CE ;
Frilling, A ;
Malago, M .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :569-573
[3]  
Busuttil RW, 2004, ANN SURG, V240, P459
[4]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[5]   Adult living donor liver transplantation for patients with hepatocellular carcinoma -: Extending UNOS priority criteria [J].
Gondolesi, GE ;
Roayaie, S ;
Muñoz, L ;
Kim-Schluger, L ;
Schiano, T ;
Fishbein, TM ;
Emre, S ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGERY, 2004, 239 (02) :142-149
[6]   Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation? No, never [J].
Hiatt, JR ;
Carmody, IC ;
Busuttil, RW .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :573-577
[7]   Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations [J].
Hwang, S ;
Lee, SG ;
Joh, JW ;
Suh, KS ;
Kim, DG .
LIVER TRANSPLANTATION, 2005, 11 (10) :1265-1272
[8]   Living-donor liver transplantation for hepatocellular carcinoma [J].
Kaihara, S ;
Kiuchi, T ;
Ueda, M ;
Oike, F ;
Fujimoto, Y ;
Ogawa, K ;
Kozaki, K ;
Tanaka, K .
TRANSPLANTATION, 2003, 75 (03) :S37-S40
[9]   Epidemiology of hepatocellular carcinoma [J].
Kew, MC .
TOXICOLOGY, 2002, 181 :35-38
[10]   The role and limitation of living donor liver transplantation for hepatocellular carcinoma [J].
Lo, CM ;
Fan, ST ;
Liu, CL ;
Chan, SC ;
Wong, J .
LIVER TRANSPLANTATION, 2004, 10 (03) :440-447